San Diego, CA – October 20, 2021 (Investorideas.com Newswire) GBT Technologies Inc. (OTC PINK: GTCH) (“GBT” or the “Company”) has on its roadmap, a wearable version of the qTerm device. The finger-touch version prototype of the device is now under manufacturing; and the company plans to start a wearable version next year. GBT’s qTerm, a human vitals device, is aimed to measure human vitals with the touch of a finger.
According to Gartner’s (Gartner Forecasts Global Spending on Wearable Devices to Total $81.5 Billion in 2021) forecast, the world will spend about $81.5 billion on wearable devices in 2021, a significant rise compared to 2020. This rise is directly correlated with the global pandemic and the importance of health monitoring in our lives.
The qTerm wearable device is planned to have all features of the finger-touch version plus additional features that can be utilized due to its shape characteristics. Upon a user’s permission; an automatic scheduled monitoring feature is planned for on-going health observation. The device’s AI system will learn about the user’s health concerns and conditions, and perform health checks as part of a daily routine, transparent to the user. Even if users forget to take vitals measurements, the device will do it automatically for them. Based on the device’s cognitive and reasoning capabilities, automatic vitals measurements will be taken continuously throughout the day. In case of abnormal results, the device will alert, and advice on further steps; the device can be integrated with clinics and hospital data systems to keep and monitor patient’s records. It will be able to directly alert physicians about any health-related concerns and could also be used during telemedicine sessions. The wearable device plans to use optical sensors technology with an advanced display. Additionally, a web portal synchronized with a mobile application is planned to support qTerm’s wearable version. And just like the finger-touch version, the data will be securely kept and transferred to a back-end AI program for further analysis and monitoring. Due to the device’s nature, GBT will continue evaluating the addition of more wearable-oriented features to increase its added value. GBT plans to start the device’s design in early 2022.
“It is only natural to create a wearable version of qTerm technology. One of the major advantages of a wearable form of qTerm is its capabilities to take health related measurements; independently, and without the user’s awareness, this feature can be enabled upon the user’s permission. We see this feature as a great advantage; especially, when users may forget to take their scheduled vitals, not aware of a potential problem. The wearable version of qTerm will be equipped with the same AI system for on-going health monitoring, and it will learn about a user’s health condition and perform scheduled checks to ensure good health. These checks will be executed throughout the day or night and in case of abnormalities the user will be alerted, and can be an efficient health monitoring system for the elderly; 24/7. In qTerm’s finger-touch version the responsibility to perform a vitals check lies on the user remembering to take these on time. However, with the wearable device the checks will be automatically executed throughout the day in case the user forgets their daily health-related duties, this system will do it for them. qTerm wearable will include a website synchronized mobile application for results representation. This advanced mobile application will make the qTerm wearable device a personal health monitoring system constantly on the watch, checking, analyzing and advising/alerting about any health concerns,” said Danny Rittman the Company’s CTO.
There is no guarantee that the Company will be successful in researching, developing or implementing this system. In order to successfully implement this concept, the Company will need to raise adequate capital to support its research and, if successfully researched, developed, the Company would need to enter into a strategic relationship with a third party that has experience in manufacturing, selling and distributing this product. There is no guarantee that the Company will be successful in any or all of these critical steps.
GBT Technologies, Inc. (OTC PINK: GTCH) (“GBT”) (http://gbtti.com) is a development stage company which considers itself a native of Internet of Things (IoT), Artificial Intelligence (AI) and Enabled Mobile Technology Platforms used to increase IC performance. GBT has assembled a team with extensive technology expertise and is building an intellectual property portfolio consisting of many patents. GBT’s mission, to license the technology and IP to synergetic partners in the areas of hardware and software. Once commercialized, it is GBT’s goal to have a suite of products including smart microchips, AI, encryption, Blockchain, IC design, mobile security applications, database management protocols, with tracking and supporting cloud software (without the need for GPS). GBT envisions this system as a creation of a global mesh network using advanced nodes and super performing new generation IC technology. The core of the system will be its advanced microchip technology; technology that can be installed in any mobile or fixed device worldwide. GBT’s vision is to produce this system as a low cost, secure, private-mesh-network between all enabled devices. Thus, providing shared processing, advanced mobile database management and sharing while using these enhanced mobile features as an alternative to traditional carrier services.
Certain statements contained in this press release may constitute “forward-looking statements”. Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements because of various important factors as disclosed in our filings with the Securities and Exchange Commission located at their website (http://www.sec.gov). In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors including (without limitation) general industry and market conditions and growth rates, economic conditions, governmental and public policy changes, the Company’s ability to raise capital on acceptable terms, if at all, the Company’s successful development of its products and the integration into its existing products and the commercial acceptance of the Company’s products. The forward-looking statements included in this press release represent the Company’s views as of the date of this press release and these views could change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company’s views as of any date subsequent to the date of the press release.
Dr. Danny Rittman, CTO
GBT Technologies Inc. (OTC Pink: GTCH) is a featured tech stock on Investorideas.com
More info on GTCH at Investorideas.com Visit: https://www.investorideas.com/CO/GOPH/
TechSectorStocks.com – investing ideas in tech stocks- mobile payments, social media, AI and Robotics, Drone Stocks, GPS, Internet of Things (IoT)
Like Tech Stocks? View our Tech Stocks Directory